Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
To meet rising interest, the FDA approved semaglutide with a new name, Wegovy, to help with long-term weight control
Trnh by SK: 734/2021/KSP
Phase 3 trials will provide a clearer side-effect picture
Innovations and policy updates drive equity and a record number of lifesaving organ transplants in 2023
Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), work through multiple mechanisms that influence gastric function
Hyperpolarized (13) C magnetic resonance evaluation of renal ischemia reperfusion injury in a murine model
US$ 24.96
US$ 28.01
US$ 25.25
US$ 29.11
US$ 21.54
US$ 23.86
US$ 27.11
US$ 24.56
US$ 22.79
US$ 26.24
US$ 28.41
